Pulsed Electromagnetic Fields for Analgesia Post Mastectomy
Use of a Wearable Device Which Generates an Electromagnetic Pulsed Field for Postoperative Analgesia of Mastectomies
European Institute of Oncology
160 participants
May 9, 2023
INTERVENTIONAL
Conditions
Summary
Study aim is to test AlgoCare, a device that uses the technology PEMF (Pulsed ElectroMagnetic Fields) for the treatment of postoperative pain in oncological breast surgery, in order to demonstrate that the use of Algocare in the postoperative period allows for a reduction in pain intensity in terms of Numerical Rating Scale (NRS) score and use of analgesic drugs.
Eligibility
Inclusion Criteria1
- Breast cancer patients undergoing unilateral mastectomy with reconstruction and without axillary dissection
Exclusion Criteria3
- Patients with PaceMakers (PMs), Implantable Cardioverter Defibrillators (ICDs), neurostimulators or other active medical devices or metal implants near the application area
- Pregnancy
- Amyloidosis, sarcoidosis, scleroderma, infectious arthritis, Paget's disease or joint tumors
Interventions
Device that emits Pulsed Electromagnetic Fields
Device that doesn't emit Pulsed Electromagnetic Fields
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06331793